MEDIFAST (MED)
(Delayed Data from NYSE)
$25.74 USD
-0.36 (-1.38%)
Updated May 31, 2024 04:00 PM ET
After-Market: $25.74 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
A Value A Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$25.74 USD
-0.36 (-1.38%)
Updated May 31, 2024 04:00 PM ET
After-Market: $25.74 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
A Value A Growth C Momentum A VGM
Zacks News
Zacks.com featured highlights include: Conduent, Medifast, Commvault, Molina and Fortinet
by Zacks Equity Research
Zacks.com featured highlights include: Conduent, Medifast, Commvault, Molina and Fortinet
Is MEDIFAST INC (MED) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Is (MED) Outperforming Other Consumer Staples Stocks This Year?
United Natural (UNFI) Q4 Earnings Up Y/Y, Stock Declines
by Zacks Equity Research
United Natural's (UNFI) Q4 earnings and sales increase year over year. However, both the metrics miss the Zacks Consensus Estimate.
5 Best-Ranked Liquid Stocks for Impressive Returns
by Zacks Equity Research
Here are five marvelous liquid stocks that investors should snap up now for stellar returns.
MEDIFAST Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
MEDIFAST has been struggling lately, but the selling pressure may be coming to an end soon.
Looking for a Top Momentum Pick? Why Medifast (MED) is a Great Choice
by Zacks Equity Research
Does Medifast (MED) have what it takes to be a top stock pick for momentum investors? Let's find out.
General Mills (GIS) Tops Q1 Earnings, Misses Sales Estimates
by Zacks Equity Research
General Mills' (GIS) earnings mark its second straight beat, whereas sales miss estimates for the third consecutive time in Q1.
Kellogg Hits 52-Week High on Cost Cut Plans and Acquisitions
by Zacks Equity Research
Kellogg (K) gains from the RXBAR and Pringles acquisitions as well as the consolidation of Multipro. Its savings initiatives are also on track.
Sysco Up 40% in a Year: Can Momentum Sustain Amid Cost Woes?
by Zacks Equity Research
Sysco (SYY) is gaining from strength in its U.S. Foodservice operations and focus on strategies for 2020. However, cost inflation remains a threat to margins.
4 Reasons Why You Should Invest in Archer Daniels Stock
by Zacks Equity Research
Archer Daniels' (ADM) progresses on its portfolio management initiatives, cost-savings plan and Readiness program bodes well.
Can AB InBev (BUD) Break Fall Even as Beer Brands Lose Fizz?
by Zacks Equity Research
AB InBev (BUD) suffers due to industry-wide decline in beer sales as consumers shift to healthier drinks. However, the company???s robust outlook indicates that there is an upside potential.
Hershey's Pirate Brands Buyout to Bolster Snacking Business
by Zacks Equity Research
Hershey (HSY) inks a deal to buy Pirate Brands from B&G Foods. Pirate Brands will be included as part of Amplify.
Campbell Down 7% in 6 Months: High Costs Not the Only Factor
by Zacks Equity Research
Campbell (CPB) posts negative sales surprise in six of the past seven quarters. The company has also been witnessing strained margins due to cost inflation.
3 Food Stocks to Buy That Are More Appetizing Than Industry
by Zacks Equity Research
While companies in the space are facing cost barriers, there are many hidden gems which have defied the industry trends with their solid strategic endeavors.
International Unit Helps Church & Dwight Reach 52-Week High
by Zacks Equity Research
Impressive second-quarter 2018 performance and robust international business drive Church & Dwight (CHD).
Here's What You Should Know About Mondelez's Long-Term Goals
by Zacks Equity Research
Mondelez (MDLZ) provides long-term targets and guidance for 2019, and reiterates projections for 2018 considering its long-term strategy.
Zacks.com highlights: athenahealth, Medifast, Commvault Systems, Molina Healthcare and Fortinet
by Zacks Equity Research
Zacks.com highlights: athenahealth, Medifast, Commvault Systems, Molina Healthcare and Fortinet
Bet on These 5 Top Liquid Stocks for Stellar Returns
by Zacks Equity Research
Five top-ranked liquid stocks that are poised to offer marvelous returns.
Can Campbell's Plans Post Strategic Review Revive the Stock?
by Zacks Equity Research
Campbell (CPB) unveils various actions as part of its prudent portfolio review and Board-led strategy, aiming at improving performance that has been drab otherwise.
5 Reasons Why Helen of Troy Stock Must be in Your Portfolio
by Zacks Equity Research
Helen of Troy (HELE) is likely to keep its stellar show on, evident from its raised earnings outlook for fiscal 2019.
Is MEDIFAST INC (MED) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Is (MED) Outperforming Other Consumer Staples Stocks This Year?
The Zacks Analyst Blog Highlights: Turtle Beach, BioLife Solutions, IntriCon and Medifast
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Turtle Beach, BioLife Solutions, IntriCon and Medifast
Church & Dwight's International Unit Strong, Margins Soft
by Zacks Equity Research
Church & Dwight's (CHD) consumer international business has been consistently contributing to organic sales growth. However, gross margin has been declining for a while now.
Boston Beer (SAM) Surges Despite Beer Woes: Will it Persist?
by Zacks Equity Research
Boston Beer (SAM) rallies despite industry headwinds, including a soft beer category, a shift to healthier drinks and higher costs. The company's non-beer portfolio shows potential for further growth.
Trump's Approval Rating Buoy Wall Street: 4 Top Gainers
by Nitish Marwah
Trump's pro-growth agenda has worked wonders for the economy as a whole.